What is the impact, present and future, of novel targeted agents in acute lymphoblastic leukemia?-Reference-Cited by-同舟云学术

What is the impact, present and future, of novel targeted agents in acute lymphoblastic leukemia?

Published:2012-12 Issue:4 Volume:25 Page:453-464
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Douer Dan

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference88 articles.

1. Modern therapy of acute lymphoblastic leukemia;Bassan;J Clin Oncol,2011

2. Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?;Douer;Best Pract Res Clin Haematol,2008

3. Acute lymphoblastic leukemia;Alvarnas;J Natl Compr Canc Netw,2012

4. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century;Pulte;Blood,2009

5. Intensification of induction and consolidation improves only subgroups of adult ALL: analysis of 1200 patients in GMALL study 05/93;Gökbuget;Blood,2001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new insight updates in diagnosis and management of acute lymphoblastic leukemia, cytogenetics, immunophenotyping, and proteomic profile;Electronic Journal of General Medicine;2023-09-01

2. Lymphoid Leukemias in Adults;The American Cancer Society's Oncology in Practice;2018-02-16

3. The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute Leukemias;Molecular Cancer Therapeutics;2015-02-09

4. Acute Lymphoblastic Leukemia in Adolescents and Young Adults;Acta Haematologica;2014

5. An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemia;Medical Oncology;2013-10-18